Indication
Mycosis
4 clinical trials
11 products
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection vs. Intravenous Caspofungin Followed by Oral Fluconazole Step Down in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisStatus: Completed, Estimated PCD: 2021-10-07
Product
FluconazoleProduct
Intravenous PlaceboProduct
Oral PlaceboProduct
RezafunginProduct
CaspofunginClinical trial
A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study)Status: Recruiting, Estimated PCD: 2024-08-01
Product
PosaconazoleClinical trial
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell LymphomaStatus: Completed, Estimated PCD: 2021-11-06
Product
Anti-thymocyte globulinProduct
cyclosporineClinical trial
Open-Label, Randomized Study to Estimate Safety, PK, and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Standard-of-Care Following IV Echinocandin Therapy in the Treatment of Invasive Candidiasis in Hospitalized Nonneutropenic AdultsStatus: Completed, Estimated PCD: 2016-06-01
Product
SCY-078Product
Micafungin